Christopher Granger, Md: Optimizing Stroke Prevention For Atrial Fibrillation

Christopher Granger, MD: Optimizing Stroke Prevention for Atrial Fibrillation

Preventing Stroke in Atrial Fibrillation: Unrealized Opportunities , with Christopher Granger, MD

University of Ottawa Heart Institute

IMPACT AF Christopher B Granger, MD

How to Improve Stroke Prevention in Patients with Atrial Fibrillation

University of Colorado School of Medicine

DRF 18: Stroke Prevention in Atrial Fibrillation

Duke Clinical Research Institute

Experts Debate: Initial Drug of Choice for Stroke Prevention in Atrial Fibrillation

NAThrombosisForum

Strategies Used for Stroke Prevention in Atrial Fibrillation

Christopher Granger, MD: Patient Tolerability of Anticoagulants

Dosing and Adverse-Effect Management With NOACs

Case: Approaches to Anticoagulation for Atrial Fibrillation

Risk Factors & Comorbidities Associated with Atrial Fibrillation

Preventing Stroke In Atrial Fibrillation

The Keyhole Heart Clinic

New Study on Wearables for Stroke Prevention in Patients With Atrial Fibrillation

Breakthroughs for Physicians

The Next Best Thing in Clinical Cardiology

Choices Available to Prevent Stroke in Patients with Atrial Fibrillation

Healthy Dialogues

Stroke Prevention in Atrial Fibrillation

ClevelandClinicCME

Atrial fibrillation and stroke

Heart Research Institute

Atrial Fibrillation Stroke Risk and Prevention

Canadian Heart Rhythm Society

SPAF Trials: Update - Christopher B. Granger, MD

CMEducationResource

MANAGING ATRIAL FIBRILLATION: BEYOND ANTICOAGULATION (Peter Leong-Sit) H&S Clinical Update 2016